APEX1 and cancer: Several pathologies, mostly cancers, are associated with either altered APE1 subcellular localization [14–16], expression levels (mostly overexpression) [17–19], or hyperacetylation [20, 21], suggesting the importance of a fine-tuning mechanism for APE1 nuclear-associated processes.